Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

How to tackle the future financial challenges in Personalised Medicine in Europe?


Published on

Presentation of Dr Wouter Spek, Managing director of EuroBioForum for the European Personalised Medicine Association (EPEMED) 2013 Spring series of webinars on 24 April 2013.

  • Be the first to comment

  • Be the first to like this

How to tackle the future financial challenges in Personalised Medicine in Europe?

  1. 1. How to tackle the future financial challengesin Personalised Medicine in Europe?Dr Wouter Spek, Managing director EuroBioForum24 April 2013 *EPEMED webinar
  2. 2. OVERVIEW webinar• Introduction– W. Spek & EuroBioForum– Situation in Europe now1. What is the role of funders?2. What kind of financial incentives we need?3. How can we achieve convergence• Conclusions– Live discussion
  3. 3. WOUTER SPEK• PhD in biology– Leiden University (NL) & University California, San Diego (USA)• Some 20 years of experience (RDTI strategy & finance)– Biotech > Genomics > Life Sciences > Pmed• International– FPs, COST, EUREKA, HTC (USA), BILAs (NL-FR)– Advisor Dutch Ministry of Economic Affairs (FP5 & FP6)• One of the founding fathers– Netherlands Genomics Initiative– ERA-NET on Plant Genomics• Consultant since 2008
  4. 4. EuroBioForum• Forum for research funders and performersin Personalised Medicine in Europe• Scout + Connect + Activate– Annual Conferences – 2012, 2013, 2014– Personalised Medicine Observatory– Community development– Satellite meetings for special interest
  5. 5. The European union or European diversity?
  6. 6. EUROPE now• Fragmented– Let a thousand flowers bloom!• How to deal with the institutional barriers?• Limited convergence & little incentives• High level of public investments• Weak communication & information systems• Enough future-orientated?
  7. 7. Europe 2020: We need an integral chainapproach, bound by coordinated actions and strategicagenda,amongst all stakeholders at stake!
  8. 8. From mass funders to funders mess!
  9. 9. FUNDERS• Public funders– National (many per country)– European Commission• Private funders– Banks, VCs– Industry related– Charities & foundations• New breed funders– Crowdfunding– Prize competitions
  10. 10. How to align 1,000 projects to improver.o.i. and deliver better healthcare for all?
  11. 11. OVERVIEW partial
  12. 12. CONSIDER this
  13. 13. What kind of financial incentives we need?
  14. 14. FINANCIAL SCHEMES needed• Fit & Match• Horizon 2020• Small is (also) beautiful• WE NEED!– The right instruments, for the right objective,to deliver the right results!
  15. 15. from Financial Strategy to Financial Engineering
  16. 16. Take home messages• Smart integration of finance• Funding for convergence• Small is (also) beautiful• Information exchange is key
  17. 17. 2nd Annual Conference:A collaborative approach27 – 28 May 2013, Munich, GermanyJoin us and register
  18. 18. LIVEDISCUSSIONContact me directlyfor further questions:Wouter